Citalopram hydrobromide is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed as an antidepressant to treat major depressive disorder, panic disorder, and social anxiety disorder. In pharmaceutical… Read more
Citalopram hydrobromide is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed as an antidepressant to treat major depressive disorder, panic disorder, and social anxiety disorder. In pharmaceutical development and manufacturing, rigorous analytical testing is essential to ensure the safety and efficacy of the active pharmaceutical ingredient. Laboratories rely on high-quality reference standards of citalopram hydrobromide, alongside its pharmacopeial and non-pharmacopeial impurities, to facilitate accurate impurity profiling during method validation and stability studies. Furthermore, metabolites and stable isotope-labelled compounds are critical for precise quantitative analysis, enabling researchers to track metabolic pathways and maintain stringent quality control standards. These reference materials support compliance with regulatory requirements, providing the specificity needed for accurate identification and quantification in complex pharmaceutical matrices.
